Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma
Clinical trial NCT02502786 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02502786
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2027-07-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.